Compounding Pharmacies Market Report 2016-2021

Global Market Study on Compounding
Pharmacies: Regulatory Harmonization and
Innovation Therapeutic Areas to Boost Demand
for Compounded Drugs
R e s e a r c h
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
M a r k e t
Our offerings include pre-built reports that address every major sale, customized solutions to
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration research approach for exploring emerging technologies has allowed us to solve the
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and
provide the latest insights into these technologies when they are being commercialized. Our
ground-breaking approach allows us to deliver market solutions before the technologies reach
the market.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing
P e r s i s t e n c e
startups. PMR’s collaborative environment is committed to building industry-specific solutions by
transforming data from multiple streams into a strategic asset.
Global Compounding Pharmacies Market 2016-2021
R e s e a r c h
Report Media Releases
Global Compounding Pharmacies Market to Account for
US$ 9.7 Bn by 2021
According to the latest market report published by Persistence Market Research titled ‘Global
Market Study on Compounding Pharmacies: Asia Pacific is expected to witness highest growth by
2021’, the global compounding pharmacies market is projected to expand at a CAGR of 6%
during the forecast period (2015 - 2021). Compounding pharmacies accounted for market
revenue worth US$ 6.5 Bn in 2014 and the revenue is expected to increase to US$ 9.75 Bn by
2021.
M a r k e t
Compounding pharmacies produce personalized medicines, which can be altered by dosages,
medicinal strengths, forms, and medium of administration, under the guidance of licensed
pharmacists and physicians. The market for compounding pharmacies – though shrouded by
regulatory restrictions and product quality conformations – presents a lucrative opportunity as
compounded drugs offer ease of accessibility, affordability, and administration to potential
customers. The report analyzes the global compounding pharmacies market in terms of market
value by end use, product, region, and therapeutic area; and provides information regarding
regional market dynamics, regulations, PEST analysis, competitive landscape, current trends,
market estimations, and forecast.
P e r s i s t e n c e
For More Information Request TOC (desk of content material), Figures and Tables of the
report @ http://www.persistencemarketresearch.com/market-research/compoundingpharmacies-market/toc
Among therapeutic segments, compounding pharmacies find largest application in the pain
management industry followed by hormone replacement therapy and others. The hormone
replacement therapy segment is expected to gain traction in the near future due to increasing
demand for anti-ageing solutions. Increasing demand for high-quality dermatological products is
also influencing manufacturers to opt for better quality active pharmaceutical ingredients and
maintain a sterile microbial contamination-free manufacturing space. Creams and gels are the
most popular products in dermatology, followed by transdermal application products, largely
popular in tropical countries.
By end use type, the compounding pharmacies market is segmented into medications for adults,
children, and geriatric population along with veterinary drugs. Medications for the adult segment
Global Compounding Pharmacies Market 2016-2021
R e s e a r c h
is expected to dominate the overall compounding pharmacies market by the end of the forecast
period. The segment is projected to register an above average growth rate over the forecast
period. However, veterinary compounded drugs are also gaining traction as these drugs are
available in alternate forms and in varying strengths not commercially available.
Download Report Sample @ http://www.persistencemarketresearch.com/samples/5270
Globally, Asia Pacific is expected to dominate the market throughout the forecast period, driven
by the promotion of innovative therapies and product formulations by major players in the
market. Singapore and Australia are the two major growth promoting countries for compounding
pharmacies in Asia Pacific. The compounding pharmacies market in Singapore is expected to
M a r k e t
increase from a current estimated value of US$ 204.9 Mn in 2015 to US$ 387.2 Mn by 2021,
registering a CAGR of 11% over the forecast period. Increase in demand for drugs prone to
medicinal drought, personalized dosages, and innovative therapeutic areas is expected to boost
overall demand for compounding pharmacies worldwide. Upcoming regulatory harmonization
and the need for manufacturing facilities to adhere to good manufacturing practices listed under
the U.S. and EU pharmacopeias are set to standardize the compounding pharmacies market.
Compounded drug manufacturers in Australia have been mandated to adhere by rules listed
under the Australian Therapeutic Goods Administration (TGA). Latin America and Europe are the
subsequent lucrative destinations for compounding pharmacies.
Key market players covered in the report include B. Braun Melsungen AG Company, Fagron,
P e r s i s t e n c e
PharMEDium Services LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle
Compounding Pharmacies, Lorraine’s Pharmacy, and Fresenius Kabi AG.
Read the full report – ‘Global Market Study on Compounding Pharmacies: Asia Pacific is expected
to witness highest growth by 2021’ with complete TOC
@ http://www.persistencemarketresearch.com/market-research/compounding-pharmaciesmarket.asp
Global Compounding Pharmacies Market 2016-2021
R e s e a r c h
About Us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Our offerings include pre-built reports that address every major sale, customized solutions to
M a r k e t
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration research approach for exploring emerging technologies has allowed us to solve the
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and
provide the latest insights into these technologies when they are being commercialized. Our
ground-breaking approach allows us to deliver market solutions before the technologies reach
the market.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing
startups. PMR’s collaborative environment is committed to building industry-specific solutions by
P e r s i s t e n c e
transforming data from multiple streams into a strategic asset.
Contact Us:
Persistence Market Research
90 Sate Street, Suite 700 Albany, NY 12207
Tel: +1-518-618-1030
Email: [email protected]
Website: http://www.persistencemarketresearch.com/
[email protected]
Stay updated with our official Blog: http://pmrblog.com
Global Compounding Pharmacies Market 2016-2021

the global compounding pharmacies market is expected to account for US$ 9.75 Bn at a CAGR of 5.3% over the forecast period (2015 - 2021).